stooocks.com

Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.

Shanghai Pharmaceuticals Holding Co., Ltd.

China · HKEX: 2607.HK · Market cap: · P/E: · P/S:

Shanghai Pharmaceuticals makes and sells medicines, and also runs a large network that distributes drugs to hospitals and pharmacies across China.

Shanghai Pharmaceuticals is one of China's biggest drug companies, and it does two very different jobs. It makes medicines — both its own branded drugs and generic copies — and it also runs a massive distribution network that moves pills and medical products from factories to hospitals and drugstores. If you picture a hospital in China ordering its medicine, there's a good chance a company like this one is somewhere in the chain, either making the product or getting it to the bedside.

The distribution arm is the workhorse. It operates a sprawling logistics system that stores and delivers pharmaceuticals, healthcare products, and medical devices to thousands of hospitals and pharmacies, mostly in China. That business is big but thin-margin, like a delivery service for medicine. The manufacturing side — where it develops and produces its own drugs — is smaller in revenue but more profitable, and it's where the company hopes to grow as China pushes for higher-quality domestic medicines. A key part of the story is traditional Chinese medicine. Shanghai Pharmaceuticals owns well-known herbal medicine brands that have been sold in China for decades, and these carry strong customer loyalty and decent pricing power. The company also invests in research and development, makes vaccines through partnerships, and has been expanding its reach internationally.


The business is deeply tied to China's healthcare system and government policy. When Beijing changes how hospitals buy drugs or how much it will pay for them, that ripples straight through this company's sales. Competition is fierce, especially from other large Chinese drugmakers and distributors, and price cuts on medicines have squeezed margins across the industry. The company raised money on the Hong Kong exchange and pays dividends to shareholders, but its fortunes rise and fall with the health of China's medical spending.

Saved answer · last researched 15 Nov 2026